Get started
Author

Lurdes Zamora

Observed names: L Zamora, L. Zamora, Lourdes Zamora, Lourdes Zamora-Plana, Lurdes Zamora Plana, Zamora Lurdes, Zamora Plana, Lurdes, Zamora, L., Zamora, Lurdes
Observed institutions: Universitat Autònoma de Barcelona, Hospital Universitari i Politècnic La Fe, Josep Carreras Leukaemia Research Institute, Institut Català d'Oncologia, Institut Municipal d'Assistència Sanitària, Hospital Del Mar, Municipal Institute for Medical Research, Hospital Universitari Germans Trias i Pujol, Ospedale San Luigi Gonzaga, Hospital del Mar Research Institute, University of Turin, Universitat de Barcelona
ORCID: 0000-0003-1713-7110
Observed ORCID: 0000-0003-1713-7110
OpenAlex ID: A5087964828
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
2022 · Elsa Bernard, Heinz Tuechler, et al. · NEJM Evidence · 864
Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor Are Associated with Improved Survival in Gefitinib-Treated Chemorefractory Lung Adenocarcinomas
2005 · Miguel Taron, Yukito Ichinose, et al. · Clinical Cancer Research · 334
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms
2020 · Laura Palomo, Manja Meggendorfer, et al. · Blood · 178
Genetic Imbalances in Progressed B-Cell Chronic Lymphocytic Leukemia and Transformed Large-Cell Lymphoma (Richter's Syndrome)
2002 · Sílvia Beà, Armando López-Guillermo, et al. · American Journal Of Pathology · 101
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
2024 · Elsa Bernard, Robert P. Hasserjian, et al. · Blood · 86
PDF
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
2020 · Josep-Maria Ribera, Mireia Morgades, et al. · Blood · 85
Molecular and clinical presentation of UBA1 -mutated myelodysplastic syndromes
2024 · Maria Sirenko, Elsa Bernard, et al. · Blood · 58
PDF
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols
2015 · Jordi Ribera, Jordi Ribera, et al. · Cancer · 53
PDF
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
2021 · Alex Bataller, Ana Garrido, et al. · Blood Advances · 52
Bone marrow fibrosis in myelodysplastic syndromes: a prospective evaluation including mutational analysis
2016 · Fernando Ramos, Spanish Group for Myelodysplastic Syndromes (GESMD), et al. · Oncotarget · 48
PDF
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia
2019 · Eulàlia Genescà, Mireia Morgades, et al. · Haematologica · 47
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease
2020 · Alex Bataller, Guadalupe Oñate, et al. · British Journal of Haematology · 46
PDF
Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies
2019 · Monica S. Ventura Ferreira, Martin Kirschner, et al. · Annals of the New York Academy of Sciences · 44
PDF
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
2021 · CETLAM group, M. Cabezón, et al. · Clinical Epigenetics · 42
PDF
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia
2019 · Laura Palomo, Mariam Ibáñez, et al. · British Journal of Haematology · 41
PDF
Natural history and cell of origin of TCF3-ZNF384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL
2019 · Clara Bueno, J. Ramón Tejedor, et al. · Blood · 33
PDF
Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia
2015 · Blanca Xicoy, Ulrich Germing, et al. · European Journal Of Haematology · 29
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
2018 · E. Genescà, A. Lazarenkov, et al. · Journal of Hematology & Oncology · 28
PDF
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features
2016 · Laura Palomo, Olga Garcia, et al. · Oncotarget · 28
PDF
Two cases of tetrasomy 9p syndrome with tissue limited mosaicism
2003 · Elisabet Lloveras, C. Pérez, et al. · American Journal of Medical Genetics Part A · 26
Diagnostic and prognostic contribution of targeted NGS in patients with triple‐negative myeloproliferative neoplasms
2019 · Pamela Acha, Marisol Xandri, et al. · American Journal of Hematology · 25
PDF
Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis
2021 · Jeannine Diesch, Marguerite-Marie Le Pannérer, et al. · Nature Communications · 24
PDF
miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk
2020 · F. Ferrer-Marín, A. B. Arroyo, et al. · Leukemia · 24
PDF
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics
2020 · Ricardo Sánchez, Jordi Ribera, et al. · Blood Cancer Journal · 23
PDF
Co-existence ofJAK2V617F andCALRmutations in primary myelofibrosis
2015 · Lurdes Zamora, Blanca Xicoy, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 23
Works count: 287
Citation count: 2,960
H-index: 23
I10-index: 49
Year
Topic
Type